The Price of Growth: Founders’ Dilution

Founders of a company considering the various available fundraising options often ask the challenging question: Why take venture capital money, which may significantly dilute the founders and might result in a loss of control of the company? Although the venture capital path is always a possibility, founders are often concerned about the consequences of such … Continue reading “The Price of Growth: Founders’ Dilution”

14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)

We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here, with looks at key studies in lung cancer, Alzheimer’s disease, asthma, and more. In part two, we examine studies in leukemia, … Continue reading “14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)”

14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)

[Updated, 4:28 pm ET, see below] After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical data—usually from big, late-stage studies—that can sometimes make or break a company. There were high profile successes in 2016. Biogen (NASDAQ: [[ticker:BIIB]]) and Ionis Pharmaceuticals (NASDAQ: … Continue reading “14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)”

Industry Needs Common Security Standards to Thwart IoT Attacks

A silver lining has emerged in the wake of the massive and well-publicized denial-of-service attack launched less than two months ago by hackers using millions of IoT devices to cripple the websites of major companies like Amazon, Netflix and Twitter. This ambush has triggered a redoubling of efforts to focus on the need for industry-led … Continue reading “Industry Needs Common Security Standards to Thwart IoT Attacks”

Zipari Receives $7,000,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7249c20d-8dfe-401b-b590-0ced38c439ef Date 12/21/2016 Company Name Zipari Mailing Address 20 Jay Street Brooklyn, NY 11201 USA Company Description Zipari is committed to making it easy to understand, buy and use health insurance. Our health insurance platform is 100% cloud-based and HIPAA compliant, making it not only cost effective and agile, but also very … Continue reading “Zipari Receives $7,000,000 Series A Financing Round”

Dynamic Yield Receives $22,000,000 Series C Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f8d213d-af1f-44a2-816e-601fcccb900a Date 12/21/2016 Company Name Dynamic Yield Mailing Address 175 Varick Street New York, NY 10014 USA Company Description Personalization, Recommendations, 1:1 Messaging and Yield Optimization Across Web, Mobile and Email. Website http://www.dynamicyield.com Transaction Type Venture Equity Transaction Amount $22,000,000 Transaction Round Series C Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Dynamic Yield Receives $22,000,000 Series C Funding”

eVisit Garners $4,395,580 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a1ce446-930b-411e-bfe3-81a05925db1c Date 12/21/2016 Company Name eVisit Mailing Address 235 East 42nd Street New York, NY 10017 USA Company Description The official corporate Twitter feed for Pfizer Inc., makers of prescription medicines, vaccines and consumer products. Website http://www.pfizer.com Transaction Type Venture Equity Transaction Amount $4,395,580 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “eVisit Garners $4,395,580 New Funding Round”

Acelity Sells LifeCell Tissue Repair Unit to Allergan for $2.9B

San Antonio — Acelity, the San Antonio maker of wound healing technologies and tissue repair products, has sold one of its business units called LifeCell to Dublin-based biopharmaceutical company Allergan for $2.9 billion. The sale of Acelity’s so-called regenerative medicine division, LifeCell, is an attempt by the company to focus its business on its core wound … Continue reading “Acelity Sells LifeCell Tissue Repair Unit to Allergan for $2.9B”

What Is Causing Startups to Go Bankrupt?

Many startups have a great product that’s viable, marketable, and ripe with potential. But if that was the only indicator of success, then nine out of 10 startups wouldn’t fail. The annals of startup history wouldn’t be littered with instances of companies like Friendster or Color that had fantastic products, but eventually sank. The truth … Continue reading “What Is Causing Startups to Go Bankrupt?”

7 Ways to Secure Your Connected Devices Against Hackers

’Tis the season for giving gifts. And increasingly, those shiny new toys and gadgets can be connected to the Internet—from TVs to watches, speakers to Barbie dolls. That Internet connection opens up a ton of possibilities for how we can use and enjoy our new devices. (“Alexa, play my Christmas playlist on Spotify, and also … Continue reading “7 Ways to Secure Your Connected Devices Against Hackers”

Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug

Slowly but surely, a new group of drugs known as “PARP” inhibitors are starting to become fixtures in the regimens for women with ovarian cancer—and perhaps more. With the approval of a drug called rucaparib (Rubraca) from Clovis Oncology, two have now been approved since 2014—and a third, from Waltham, MA-based Tesaro (NASDAQ: [[ticker:TSRO]]), could … Continue reading “Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug”

Creating Bio “Gestalt” And Photos From New York Life Sciences 2021

New York City Deputy Mayor Alicia Glen said it best: “It’s about creating what I call a ‘New York gestalt’ around life sciences.” Showing that New York biotech can rise above its problems, become greater than the sum of its currently disparate parts, and create a brand that ranks up there with Wall Street, the … Continue reading “Creating Bio “Gestalt” And Photos From New York Life Sciences 2021”

Starry Scoops Up $30M as Fixed Wireless Field Heats Up

Starry, a wireless broadband startup based in Boston and New York, has raised $30 million in new equity funding, according to a regulatory filing. The investors in the round weren’t named, but the company’s previous backers include KKR, IAC, Tiger Global, and other venture capitalists. The startup is led by CEO Chet Kanojia, the founder … Continue reading “Starry Scoops Up $30M as Fixed Wireless Field Heats Up”

COTA Obtains $18,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ec63ad5c-893f-4f89-990e-525a40f0ada2 Date 12/17/2016 Company Name COTA Mailing Address 401 Park Avenue South Hackensack, NY 10016 USA Company Description A cloud-based program which collects select oncological patient level data in order to provide unique real-time functions for oncologists Website http://www.cotatrack.com Transaction Type Venture Equity Transaction Amount $18,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “COTA Obtains $18,000,000 New Funding Round”

After Setback, Ophthotech Restructures, Dials Down Eye Drug Studies

Ophthotech’s attempt to change the standard of care for a common form of vision loss, age related macular degeneration, fell short earlier this week, sending shares spiraling downward and leaving the fate of the company and its lead drug, pegpleranib (Fovista), unclear. The company clarified two things today—its future will involve a much smaller workforce, … Continue reading “After Setback, Ophthotech Restructures, Dials Down Eye Drug Studies”

Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More

The 21st Century Cures Act is now law. New York wants to play in the biotech big leagues. The FDA under Trump will have license to approve drugs faster and could have a former top official back on board as commissioner. An eye drug failed, an Alzheimer’s drug got scrutinized, and a new antibiotic passed … Continue reading “Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More”

Qineqt Lands $1,300,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b962f1eb-99e8-4a5b-b394-9c6f8b81e861 Date 12/16/2016 Company Name Qineqt Mailing Address 33 West 17th Street 8th Floor New York, NY 10011 USA Company Description Qineqt collaborates with investment managers to build an adaptive infrastructure to define data sets and correlations that empower sophisticated investors to scale quickly, efficiently, and focus on developing investment strategies. Website … Continue reading “Qineqt Lands $1,300,000 Series A Funding”

ExplainEverything Lands $3,700,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ce0bc84-775a-4c4a-b48c-ce800c8330d8 Date 12/16/2016 Company Name ExplainEverything Mailing Address 119 West 24th Street New York, NY 10011 USA Company Description Explain Everything is the most versatile interactive whiteboard available for your device – use it for sharing knowledge, building understanding, personal productivity and much more. Website http://www.explaineverything.com Transaction Type Venture Equity Transaction Amount … Continue reading “ExplainEverything Lands $3,700,000 New Financing Round”

Zola Garners $25,000,000 Series C Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2095006b-44b5-48f1-9ac9-e820e34f2afa Date 12/16/2016 Company Name Zola Mailing Address 394 Broadway 3rd Floor New York, NY 10013 USA Company Description Zola is an innovative Wedding Registry that is transforming how couples and guests share, buy, and ship wedding gifts. Zola provides an exciting new way for modern couples to register for homewares, kitchen … Continue reading “Zola Garners $25,000,000 Series C Funding Round”

Logicworks Secures $135,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62f3f5b5-e27f-4f27-aae4-ffc36160d8a4 Date 12/16/2016 Company Name Logicworks Mailing Address 155 Avenue of the Americas Fifth Floor New York, NY 10013 USA Company Description Logicworks exclusively delivers enterprise hosting and cloud solutions to sophisticated, high-growth clients in need of high-availability for their most critical applications and content. Clients can reduce capital expenses, operating overhead … Continue reading “Logicworks Secures $135,000,000 New Funding”

Netgear Acquires Placemeter for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ff8b5893-fd03-44b2-bf31-c00357966653 Date 12/16/2016 Company Name Placemeter Mailing Address 349 5th Avenue New York, NY 10016 USA Company Description At the crossroads of Big Data and Internet of Things, Placemeter is a platform that senses and unlocks massive amounts of data about activity in physical places. Website http://www.placemeter.com Transaction Type M&A Transaction Amount … Continue reading “Netgear Acquires Placemeter for Undisclosed Sum”

After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another

Agios Pharmaceuticals has been developing two experimental drugs for anemia. For a couple of years, the company has said it would eventually move the better one forward and leave the other behind. As it turns out, the FDA has made the decision an easy one. Agios (NASDAQ: [[ticker:AGIO]]) said this afternoon it has scrapped AG-519, … Continue reading “After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another”

Splash Events Garners $7,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1790e457-74c2-49d6-bac6-1925c47d03a0 Date 12/15/2016 Company Name Splash Events Mailing Address 122 W 26th St. 4th Floor New York, NY 10001 USA Company Description Splash is the comprehensive events management platform that maximizes event impact – before, during, and after. Share the action as it happens, with real-time social integration and curation. Website http://www.splashthat.com … Continue reading “Splash Events Garners $7,000,000 Series B Financing Round”

Privacy Lands $2,200,000 Seed Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5ca22a13-4bf5-4b74-ac63-6dce2f9380ed Date 12/15/2016 Company Name Privacy Mailing Address Undisclosed New York, NY 11001 USA Company Description Privacy builds easy to use software that protects your digital rights. The company was founded by veterans of leading payments and security companies including American Express, Expensify, and Palantir. Website http://www.privacy.com Transaction Type Venture Equity Transaction … Continue reading “Privacy Lands $2,200,000 Seed Financing”

Collective Returns Receives $24,849,978 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=870f124a-94cc-4acf-964d-7af270c7fd81 Date 12/15/2016 Company Name Collective Returns Mailing Address 27 W 24th Street 4th Floor New York, NY 10010 USA Company Description Our solution, the Stash app, starts with you. That’s because we believe that even if you aren’t an expert investor, you have interests, beliefs, and goals that relate to investing. … Continue reading “Collective Returns Receives $24,849,978 New Funding Round”

EverCompliant Garners $9,500,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5bc2eb76-d464-4d2f-82b1-7f6f3f8a4e5e Date 12/15/2016 Company Name EverCompliant Mailing Address 19 West 21st New York, NY 10010 USA Company Description EverCompliant is a leading provider of Cyber Risk Intelligence and Transaction Laundering Detection and Prevention. Our focus is to detect and prevent transaction and money launderers, hidden transaction tunnels and merchant fraud from entering … Continue reading “EverCompliant Garners $9,500,000 New Funding”

Socure Lands $13,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0bf7dce-f1e4-408b-b982-d8764a3f5644 Date 12/15/2016 Company Name Socure Mailing Address 110 Fifth Ave. 5th Floor New York, NY 10011 USA Company Description Socure combines a patent-pending artificial intelligence system, proprietary machine learning algorithms and social behavior pattern analysis to detect if an ID is authentic, a fraudster or a bot. Website http://www.socure.com Transaction Type … Continue reading “Socure Lands $13,000,000 New Funding”

Callida Energy, RideHop Win NextEnergy’s Smart Cities Challenge

As autonomous technologies, the Internet of Things, and big data begin to shape the way we interact with the world around us, we’ll have more technological tools to tackle challenges related to safety, mobility, emissions, accessibility, and congestion. Last week, those tools were on display as part of Detroit nonprofit NextEnergy‘s 2016 Smart Cities competition … Continue reading “Callida Energy, RideHop Win NextEnergy’s Smart Cities Challenge”

50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them

If you’re not much of a podcast listener and you have a sense that you’re missing out on a lot of great content, you’re absolutely right. But now is a good time to fix that, thanks to a new profusion of listening options. And to get you started, I have a few shows to suggest. … Continue reading “50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them”

Managed by Q Secures $30,516,043 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=16de434d-d1cc-4340-b50e-635c9173db40 Date 12/14/2016 Company Name Managed by Q Mailing Address 50 Eldridge St. New York, NY 10002 USA Company Description Managed by Q provides office cleaning and other smart services to help your office operations run smoothly – all managed via an iPad that’s installed for free in your office. Website http://www.managedbyq.com … Continue reading “Managed by Q Secures $30,516,043 New Round”

NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan

[Updated w/comments, new information, 3:45 p.m. ET, see below] Over the last two days, city and state governments in New York have combined to commit a total of $1.15 billion to the development of the life sciences industry in the Empire State, the largest biotech bet in its history. Today is New York City’s turn. … Continue reading “NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan”

Philadelphia’s goBooze Starts Beer, Wine Delivery in Austin

Austin—This past summer had been the season of alcohol delivery startups. As we go into the year-end festivities, Philadelphia-based goBooze announced today that it has expanded service to Austin. GoBooze is the alcohol delivery arm of goPuff, a delivery service company that delivers all manner of consumer products and food that says it fulfills orders in … Continue reading “Philadelphia’s goBooze Starts Beer, Wine Delivery in Austin”

GiveGab Receives $1,423,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=14037833-7738-4b73-91d4-550543bbb9ef Date 12/13/2016 Company Name GiveGab Mailing Address 130 East Seneca Street Ithaca, NY 14850 USA Company Description GiveGab is the online giving platform designed exclusively for nonprofits to raise funds and manage supporter engagement quickly and easily! Website http://www.givegab.com Transaction Type Debt Transaction Amount $1,423,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “GiveGab Receives $1,423,000 New Financing”

New York State Hatches Sprawling $650M Plan to Foster Biotech

New York Governor Andrew Cuomo announced on Monday a $650 million initiative to support the development of biotech in the state of New York, where life science businesses have had trouble for years gaining a foothold despite a strong core of biomedical research work in New York City and beyond. The plan involves three main … Continue reading “New York State Hatches Sprawling $650M Plan to Foster Biotech”

BlueRock Raises $225M To Repair Heart Damage With Stem Cells

A new stem cell therapeutics company, BlueRock Therapeutics, has launched with $225 million in funding from international healthcare giant Bayer and Versant Ventures. Using work from Nobel Prize winner Shinya Yamanaka and others, BlueRock will operate in Toronto, New York, and Boston. The company said one of its first projects aims to repair heart muscle, … Continue reading “BlueRock Raises $225M To Repair Heart Damage With Stem Cells”

ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer

[Updated, 12/14/16, 5:39 pm. See below.] Seattle startup creator Accelerator Corp. has revealed its latest investment, ApoGen Biotechnologies, a startup that plans to develop cancer drugs that can overcome the resistance tumors develop to other treatments. ApoGen has raised a $7 million Series A to get going. Investors participating in the financing include AbbVie Ventures, … Continue reading “ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer”

Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble

Ophthalmologists were keeping a close eye on an experimental drug from Ophthotech called pegpleranib (Fovista). Succeed, and the drug might change how a common form of vision loss, age related macular degeneration (AMD), is treated—and shine an even brighter spotlight on ophthalmologists already in the crosshairs of insurers and the federal government. That won’t happen, … Continue reading “Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble”

Vesper Obtains $15,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8fb7aa81-0f14-4015-bf6c-11da91fdd2b1 Date 12/12/2016 Company Name Vesper Mailing Address 26 Broadway 8th Floor New York, NY 10004 USA Company Description Office managers and business owners spend 20 hours/week on basic office tasks, like restocking supplies and scheduling repairs. Vesper takes care of it all. Website http://www.getvesper.com Transaction Type Venture Equity Transaction Amount $15,000,000 … Continue reading “Vesper Obtains $15,000,000 Series A Funding Round”

Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”

When Eli Lilly (NYSE: [[ticker:LLY]]) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the disease, some observers immediately called it a final blow for the drug. After all, it had also failed to improve a broader range of patients with … Continue reading “Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song””

Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More

What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to … Continue reading “Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More”

Hurry and Save 20 Percent on NY Life Sciences 2021

We’re just one week away from New York Life Sciences 2021, which will take place next Thursday, December 15, at Alexandria Center for Life Science. If you’re already planning on attending, there’s no need to wait any longer—our Procrastinator’s special ends today and seats are filling up fast, so act now and save 20 percent … Continue reading “Hurry and Save 20 Percent on NY Life Sciences 2021”

Wake Up, Pharma—Trump Is Not Your Savior

Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald Trump coming into office, the whole industry seems to have breathed a sigh of relief that the status quo—a continuous race toward higher prices—will last … Continue reading “Wake Up, Pharma—Trump Is Not Your Savior”

KeyMe Receives $25,000,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=55cec73d-3e4c-4a2b-a525-35115ee925ae Date 12/8/2016 Company Name KeyMe Mailing Address 45-50 30th Street Long Island City, NY 11101 USA Company Description Choose from a wide selection of key designs including sports, designer, college, and a bottle opener key. Just scan your key with the KeyMe app and choose the design. We’ll take care of … Continue reading “KeyMe Receives $25,000,000 New Financing Round”

Vestorly Lands $8,500,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=26629192-e7fb-4f7f-a911-ae094305139f Date 12/8/2016 Company Name Vestorly Mailing Address 335 Madison Avenue 3rd Floor New York, NY 10017 USA Company Description We value the unequivocal tellings of data, and seek to solve hard problems. Professional service providers have struggled with incomplete and superficial marketing solutions that are really built for the Fortune 1000. … Continue reading “Vestorly Lands $8,500,000 New Funding Round”

Waggle Obtains $2,300,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1698a5b6-0696-4f26-a220-cf3a4bda8ca9 Date 12/8/2016 Company Name Waggle Mailing Address Undisclosed New York, NY 11001 USA Company Description Waggle is a new platform for pets and animal lovers, created by Broadway Video Ventures. Waggle’s first product is a live streaming app that enables pet owners to broadcast the lives of their animal friends to … Continue reading “Waggle Obtains $2,300,000 Seed Round”

Senate Approves 21st Century Cures Act, Sending Bill to Obama

The U.S. Senate has voted overwhelmingly to approve the 21st Century Cures Act, a wide-ranging healthcare spending and reform bill that aims to infuse medical research with new funding and also speed up the regulatory approval process for new drugs and medical devices. With the Senate’s 94-5 vote on Wednesday, the bill now advances to … Continue reading “Senate Approves 21st Century Cures Act, Sending Bill to Obama”

Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study

Voyager Therapeutics this afternoon is providing very early evidence that an experimental gene therapy it’s been developing might have a chance to help patients with Parkinson’s disease for whom standard treatment is no longer working well. Cambridge, MA-based Voyager (NASDAQ: [[ticker:VYGR]]) is disclosing interim data from a small, open-label, Phase 1 trial among volunteers with … Continue reading “Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study”

First Clinical Trial Done, Elysium Lands $20M for Health Supplements

For many people looking for ways to treat illness or disease, the first thought is to pop a pill. Taking medication is a reactive approach to disease. But Eric Marcotulli, CEO of Elysium Health, says science is now revealing ways that a proactive approach can stave off disease and bodily decline. Elysium, a New York-based … Continue reading “First Clinical Trial Done, Elysium Lands $20M for Health Supplements”

ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More

Two years ago at the American Society of Hematology conference, excitement, not blood, was running in the streets of San Francisco. The cancer immunotherapy known as CAR-T was the star of the show, thanks to dazzling early data that showed more patients than not saw their leukemias and lymphomas knocked into remission by the living, … Continue reading “ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More”

Rainbow Broadband Leads Charge to Bring Fixed Wireless to Brooklyn

Microwaves belong in kitchens, right? Not according to Russ Hamm, president and founder of New York-based Rainbow Broadband. Since 2004, Hamm and his firm have been installing microwave antennas on rooftops across Manhattan capable of providing fixed wireless Internet service to hundreds of clients in a roughly two-mile radius. The devices are capable of wirelessly providing … Continue reading “Rainbow Broadband Leads Charge to Bring Fixed Wireless to Brooklyn”